Akeylink
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Akeylink - overview
Established
2021
Location
Shanghai, -, China
Primary Industry
Pharmaceuticals
About
Based in Shanghai, China and founded in 2021, Fujian Guang Sheng Zhong Lin Biotechnology Co. , Ltd. , trading as Akeylink, focuses on the research and development of innovative drugs in the fields of antiviral and liver diseases. In October 2025, Akeylink closed a Series A funding from new investor People's Capital.
The company specializes in developing innovative software solutions designed to streamline business operations and enhance productivity across various industries. The company's flagship product is a comprehensive enterprise resource planning (ERP) system that integrates key business functions such as inventory management, financial reporting, and customer relationship management into a single platform. This system allows businesses to automate processes, improve data accuracy, and foster collaboration among departments. The company’s client base includes small to medium-sized enterprises in sectors such as manufacturing, retail, and logistics, primarily serving markets in North America, Europe, and parts of Asia.
The company generates revenue through a subscription-based model, where clients pay for access to its software solutions on a monthly or annual basis.
Current Investors
People's Capital
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals, Pharmaceutical Research & Development
Website
www.akeylink.cn
Verticals
Manufacturing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.